UNC HEALTH Pharmacy and Therapeutics Series
The "UNC Health System Pharmacy and Therapeutics (P&T) Committee Series" offers healthcare professionals an in-depth exploration of key pharmacologic updates, formulary recommendations, and clinical management strategies that impact system-wide patient care. At the P&T meeting on July 21, participants will use principles of evidence-based medicine to evaluate formulary change recommendations, assess the impact of optimization initiatives, and develop strategies to optimize patient care and safety across the UNC Health Care System. This series is designed to enhance clinical decision-making, address medication safety concerns, and discuss the cost-effectiveness of therapeutic options, equipping attendees with actionable knowledge to optimize pharmacological practices across diverse healthcare settings.
Target Audience
This activity is designed for an audience of Physicians and Pharmacists.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Review key clinical and cost differences between oral 3rd generation cephalosporins for formulary class standardization
- Evaluate the efficacy of anacaulase-bcbd (Nexobrid) for the treatment of acute facial burns.
- Compare the efficacy, safety, and role of high- vs standard-dose nusinersin (Spinraza) in the treatment of SMA.
- Identify clinical and operational implications of ongoing drug shortages.
Commercial Support
There is no commercial support for this activity.
Course summary
- 1.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours. - 1.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURES | ||
Name | Relationship | Commercial Interest |
Abhi Mehrotra, MD, MBA, FACEP (faculty) | N/A | Nothing to disclose |
Ina Liu, PharmD, MS (faculty) | N/A | Nothing to disclose |
Lauren Meekins, PharmD, MS (faculty) | N/A | Nothing to disclose |
Zachary Pedretti, PharmD, BCCCP (faculty) | N/A | Nothing to disclose |
LaTisha Hitchcock, PharmD (faculty) | Advisor | Pfizer |
Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations | N/A | Nothing to disclose |
Dorothy Duffy, RPh (planner/reviewer) | N/A | Nothing to disclose |
Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
UNC Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and UNC Health. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 1.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours. - 1.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price
Criteria for Success
To obtain credit, you must complete the activity evaluation and claim credit based on your attendance. The Certificate of Completion is immediately available for download after submitting your evaluation. It will remain in your profile transcript for future retrieval if needed. It can be found under My Account > My Activities > Completed Activities.
If you have any questions, contact [email protected].

Facebook
X
LinkedIn
Forward